a 63162 has been researched along with 5,8,11,14-eicosatetraynoic acid in 3 studies
*5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a). [MeSH]
*5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a). [MeSH]
| Studies (a 63162) | Trials (a 63162) | Recent Studies (post-2010) (a 63162) | Studies (5,8,11,14-eicosatetraynoic acid) | Trials (5,8,11,14-eicosatetraynoic acid) | Recent Studies (post-2010) (5,8,11,14-eicosatetraynoic acid) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 573 | 1 | 16 |
| Protein | Taxonomy | a 63162 (IC50) | 5,8,11,14-eicosatetraynoic acid (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 1.78 | |
| Myeloid cell leukemia sequence 1 (BCL2-related) | Homo sapiens (human) | 0.4415 | |
| envelope glycoprotein | Human immunodeficiency virus 1 | 11.9 | |
| Vif | Human immunodeficiency virus 1 | 0.86 | |
| Tat | Human immunodeficiency virus 1 | 2.379 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 0.86 | |
| dual specificity protein phosphatase 6 | Rattus norvegicus (Norway rat) | 21.683 | |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 17.7 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 1.78 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KM; Harris, JE; Ondrey, F | 1 |
| Anderson, KM; Harris, JE; Jajeh, A; Levin, J; Seed, T | 1 |
| Anderson, KM; Harris, JE; Jajeh, A; Meng, J; Plate, JM; Seed, T | 1 |
1 review(s) available for a 63162 and 5,8,11,14-eicosatetraynoic acid
| Article | Year |
|---|---|
ETYA, a pleotropic membrane-active arachidonic acid analogue affects multiple signal transduction pathways in cultured transformed mammalian cells.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetamides; Animals; Cell Differentiation; Cell Division; Cell Line, Transformed; Cell Membrane; DNA; Humans; Male; Membrane Fluidity; Phenyl Ethers; Protein Kinase C; Signal Transduction; Tumor Cells, Cultured | 1992 |
2 other study(ies) available for a 63162 and 5,8,11,14-eicosatetraynoic acid
| Article | Year |
|---|---|
Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetamides; Amides; Apoptosis; Base Sequence; Blast Crisis; Blood Cells; Codon; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Microscopy, Electron; Molecular Sequence Data; Oligonucleotides, Antisense; Phenyl Ethers; Pyridines; RNA, Neoplasm; Thymidine; Tritium | 1993 |
Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetamides; Amides; Antineoplastic Agents; Apoptosis; Blast Crisis; Cell Differentiation; Cell Division; DNA, Neoplasm; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Phenyl Ethers; Pyridines; Tumor Cells, Cultured | 1995 |